China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of a novel PET molecular probe targeting CCK2R in small cell lung cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134523
Registration Time: 2026/10/15
Type: Interventional study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347719
Published by HT Digital Content Services with permission from Health Daily Digest....